CenTrial Logo

About Dementia and Alzheimer's


Alzheimer's disease is a progressive neurological disorder that primarily affects older adults, gradually impairing their memory, cognitive abilities, and daily functioning. It is the most common cause of dementia, a term used to describe a group of symptoms affecting memory, thinking, and social abilities severely enough to interfere with daily life.

Alzheimer's disease has a widespread impact on individuals, families, and society as a whole. As the population ages, the prevalence of dementia and Alzheimer's disease continues to rise, making it essential to comprehend its symptoms, available treatments, and the role of clinical trials in advancing research and potential therapies.

By exploring Alzheimer's disease and recognizing the importance of understanding its symptoms, treatments, and clinical trials, individuals can better navigate this complex condition and make informed decisions about their health and care. Through education and awareness, we can work towards improving outcomes for those affected by Alzheimer's disease and ultimately strive for better prevention and treatment strategies.

What is Alzheimer's Disease?

Alzheimer's disease is a progressive neurodegenerative disorder characterized by the gradual deterioration of brain cells, leading to a decline in cognitive function and memory loss. It is the most common cause of dementia, accounting for approximately 60-80% of all cases. While the exact cause of Alzheimer's disease is not fully understood, it is believed to involve a combination of genetic, environmental, and lifestyle factors.

About Dementia and Alzheimer's Disease

Symptoms of Alzheimer's Disease

Memory Loss

Memory loss is one of the hallmark symptoms of Alzheimer's disease, often presenting as difficulty remembering newly learned information or important dates and events. Individuals may also experience challenges in retaining recently acquired knowledge and recalling familiar names or faces. As Alzheimer's disease progresses, memory loss may become more severe, affecting daily activities and personal relationships.

Cognitive Decline

In addition to memory loss, Alzheimer's disease is characterized by cognitive decline, impacting various aspects of thinking and reasoning. This decline may manifest as difficulty with problem-solving, impaired judgment, and struggles with language, such as finding the right words or following conversations. Individuals with Alzheimer's disease may also experience confusion, disorientation, and difficulty understanding spatial relationships.

Behavioral Changes

Behavioral changes are common in individuals with Alzheimer's disease and can vary widely depending on the stage of the condition. These changes may include agitation, irritability, mood swings, and withdrawal from social activities. Some individuals may exhibit repetitive behaviors, such as pacing or hand-wringing, while others may demonstrate apathy or a loss of interest in previously enjoyed activities. Understanding and managing these behavioral changes is essential for providing quality care and support to individuals living with Alzheimer's disease.

Stages of Alzheimer's Disease

Preclinical Stage

The preclinical stage of Alzheimer's disease is characterized by the presence of biological changes in the brain, such as the accumulation of abnormal proteins like beta-amyloid and tau, without noticeable symptoms or impairment in daily functioning. During this stage, individuals may not experience any cognitive or memory problems, making it challenging to detect Alzheimer's disease through traditional diagnostic methods.

Mild, Early Stage

In the mild or early stage of Alzheimer's disease, individuals may begin to experience subtle changes in memory and cognitive function that are noticeable to themselves and close family members or friends. Symptoms during this stage may include difficulty remembering recent events or conversations, misplacing belongings, and mild challenges with problem-solving and decision-making. Despite these changes, individuals can typically maintain independence in their daily activities and may still participate in social and recreational activities.

Moderate, Middle Stage

The moderate or middle stage of Alzheimer's disease is marked by a more pronounced decline in cognitive function and increasing difficulty with daily tasks. Individuals may struggle with remembering significant details about their personal history, experience challenges with language and communication, and exhibit changes in behavior and personality. During this stage, caregivers may need to provide more assistance with activities of daily living, such as dressing, bathing, and meal preparation, as independence declines.

Severe, Late Stage

In the severe or late stage of Alzheimer's disease, cognitive impairment becomes profound, and individuals may lose the ability to communicate effectively, recognize loved ones, or perform basic tasks independently. Physical symptoms, such as difficulty swallowing, mobility issues, and incontinence, may also become more pronounced during this stage. Individuals with late-stage Alzheimer's disease require extensive assistance and round-the-clock care to meet their needs and ensure their safety and comfort.

Treatment of Alzheimer's Disease


Several medications are available for managing the symptoms of Alzheimer's disease, although none can halt or reverse the underlying progression of the condition. These medications work by targeting neurotransmitters in the brain to improve cognitive function, delay symptom progression, and enhance the quality of life for individuals with Alzheimer's disease.

One commonly prescribed class of medications for Alzheimer's disease is cholinesterase inhibitors, including donepezil, rivastigmine, and galantamine. These medications work by increasing levels of acetylcholine, a neurotransmitter involved in memory and learning, in the brain. Doing so may help improve cognitive function and alleviate symptoms such as memory loss, confusion, and difficulty with thinking and reasoning.

Another medication used to treat moderate to severe Alzheimer's disease is memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist. Memantine regulates glutamate, another neurotransmitter involved in learning and memory, to help stabilize communication between nerve cells and prevent excessive excitability in the brain. This medication may be prescribed in combination with a cholinesterase inhibitor for individuals with more advanced stages of Alzheimer's disease.

While these medications can provide temporary relief from symptoms and may help individuals with Alzheimer's disease maintain independence and functional abilities for some time, they do not alter the underlying course of the disease. As such, ongoing research is needed to develop more effective treatments and ultimately find a cure for Alzheimer's disease.

Non-pharmacological Approaches

Lifestyle Changes
Lifestyle modifications play a major role in managing Alzheimer's disease symptoms and improving overall well-being. Simple lifestyle changes, such as maintaining a healthy diet, staying physically active, and getting an adequate amount of sleep, can have a positive impact on cognitive function and may help slow the progression of Alzheimer's disease. A balanced diet rich in fruits, vegetables, whole grains, and lean proteins provides essential nutrients that support brain health and may reduce the risk of cognitive decline.

Cognitive Stimulation
Engaging in mentally stimulating activities, such as puzzles, games, reading, and learning new skills, can help keep the brain active and enhance cognitive function in individuals with Alzheimer's disease. Cognitive stimulation exercises challenge the brain and may improve memory, attention, and problem-solving abilities. Additionally, participating in social activities and maintaining social connections can provide emotional support and cognitive stimulation, contributing to overall well-being.

Physical Exercise
Regular physical exercise has been shown to have numerous benefits for people with Alzheimer's disease, including improved cardiovascular health, reduced risk of depression and anxiety, and enhanced cognitive function. Exercise promotes blood flow to the brain, stimulates the release of neurotransmitters involved in mood regulation and memory, and may even stimulate the growth of new brain cells. Activities such as walking, swimming, yoga, and tai chi are excellent options for individuals with Alzheimer's disease, as they are gentle on the joints and can be modified to accommodate varying levels of physical ability.
Incorporating these non-pharmacological approaches into daily life can complement medication therapies and help individuals with Alzheimer's disease maintain independence, cognitive function, and quality of life for as long as possible. It is essential to consult with healthcare professionals to develop a personalized treatment plan tailored to individual needs and preferences.

Clinical Trials and Alzheimer's Disease

Clinical trials play a vital role in advancing our understanding of Alzheimer's disease and developing new treatments and interventions. These research studies investigate the safety and effectiveness of potential therapies, diagnostic tools, and preventive strategies for Alzheimer's disease. By participating in clinical trials, individuals contribute to scientific knowledge and help researchers test promising treatments that may ultimately benefit future generations.

How Clinical Trials Work

Clinical trials typically follow a structured protocol designed to evaluate the safety and efficacy of an investigational intervention, such as a new medication, therapy, or medical device. The process involves several phases, including preclinical studies in laboratory settings, followed by phases I, II, and III clinical trials in human participants. Phase IV trials may also be conducted after a treatment receives regulatory approval to monitor its long-term safety and effectiveness in real-world settings.

During a clinical trial, participants may receive the investigational intervention or a placebo (inactive substance) to compare its effects with standard treatments or no treatment. Researchers collect data on various outcomes, such as changes in symptoms, cognitive function, and quality of life, to assess the intervention's impact. Clinical trials adhere to strict ethical and regulatory guidelines to protect participants' rights, safety, and confidentiality throughout the study.

CenTrial.org: Matching Patients with Alzheimer's Clinical Trials

CenTrial.org is a valuable resource for individuals interested in participating in clinical trials for Alzheimer's disease and other health conditions. As an automated matching service, CenTrial connects patients with clinical trials based on their unique health profiles and preferences. The platform utilizes advanced algorithms to analyze participants'  health profiles and match them with suitable research studies.

CenTrial provides a user-friendly interface that allows individuals to securely sign up and complete a health questionnaire that creates their health profile. This profile is used to identify potential matches with clinical trials investigating Alzheimer's disease treatments, diagnostic tools, or preventive interventions. You can review trial details, eligibility criteria, and potential risks and benefits before deciding whether or not to participate.

CenTrial does not provide medical advice or diagnoses but serves as a bridge between researchers conducting clinical trials and individuals interested in exploring new treatments and contributing to Alzheimer's research.

Frequently Asked Questions (FAQs)

What are the Risk Factors for Alzheimer's Disease?

Several factors may increase the risk of developing Alzheimer's disease, including age, genetics, and lifestyle factors. Advancing age is the most significant risk factor, with the likelihood of developing Alzheimer's disease increasing with age. Family history of Alzheimer's disease or other forms of dementia also plays a role, as certain genetic mutations and variations may predispose individuals to the condition. Lifestyle factors such as cardiovascular health, diet, physical activity, and education level may also influence Alzheimer's disease risk.

How Long Can a Person Live with Alzheimer's Disease?

The progression and course of Alzheimer's disease vary from person to person, making it challenging to predict individual life expectancy. On average, individuals diagnosed with Alzheimer's disease may live for approximately 8 to 10 years following diagnosis, although some individuals may live much longer, while others may experience a more rapid decline. Factors such as age, overall health, presence of other medical conditions, and level of care and support can all impact life expectancy in individuals with Alzheimer's disease.

Can Alzheimer's Disease Be Cured?

Currently, there is no cure for Alzheimer's disease. Available treatments focus on managing symptoms and improving the quality of life for those affected by the condition. While ongoing research aims to develop new therapies and interventions for Alzheimer's disease, finding a cure remains a significant challenge. Participating in clinical trials and supporting research efforts are essential steps toward advancing our understanding of Alzheimer's disease and identifying potential treatments and preventive strategies.

What Is the Best Treatment for Alzheimer's Disease?

The best treatment for Alzheimer's disease depends on individual factors such as the stage of the condition, overall health, and specific symptoms and needs. While medications such as cholinesterase inhibitors and memantine may help manage cognitive symptoms and improve the quality of life for some individuals, non-pharmacological approaches such as lifestyle modifications, cognitive stimulation, and physical exercise are also important components of comprehensive care. Caregiver support, social engagement, and access to community resources are also vital aspects of Alzheimer's disease management.

Is There a Surgery for Alzheimer's Disease?

Currently, there is no surgical procedure specifically for treating Alzheimer's disease. While some surgical interventions may be used to address certain complications or symptoms associated with Alzheimer's disease, such as implanting a pacemaker for heart rhythm abnormalities or performing surgery to address fractures from falls, surgery does not cure or halt the progression of Alzheimer's disease itself. Research into potential surgical approaches for Alzheimer's disease is ongoing, but no surgical treatment has yet been proven effective for the condition.

Does Alzheimer's Disease Directly Cause Death?

Alzheimer's disease itself does not directly cause death but rather contributes to a decline in overall health and functioning that may ultimately lead to complications such as infections, aspiration pneumonia, or organ failure, which can result in death. As Alzheimer's disease progresses, individuals may experience increasing difficulty with eating, swallowing, mobility, and communication, making them more vulnerable to health complications. Providing supportive care and managing symptoms effectively can help improve the well-being of individuals with Alzheimer's disease as the condition progresses.

How to Avoid Alzheimer's Disease?

While there is no guaranteed way to prevent Alzheimer's disease, adopting a healthy lifestyle and managing risk factors may help reduce the risk of developing the condition. Strategies for reducing Alzheimer's disease risk include maintaining cardiovascular health through regular exercise and a balanced diet, staying mentally and socially active, managing chronic conditions such as diabetes and hypertension, getting adequate sleep, and avoiding smoking and excessive alcohol consumption. Engaging in lifelong learning and challenging cognitive activities may also help support brain health and reduce the risk of cognitive decline.

What Foods Reduce the Risk of Alzheimer's Disease?

While no specific food or diet can prevent Alzheimer's disease, following a balanced and nutritious diet that includes a variety of fruits, vegetables, whole grains, lean proteins, and healthy fats may support brain health and reduce the risk of cognitive decline. Foods rich in antioxidants, omega-3 fatty acids, and vitamins and minerals such as vitamin E, C, and folate may be particularly beneficial for brain function. Some studies suggest that the Mediterranean diet, which emphasizes plant-based foods, fish, olive oil, and moderate wine consumption, may help reduce the risk of Alzheimer's disease and other forms of dementia. However, further research is needed to confirm these findings and better understand the role of diet in Alzheimer's disease prevention.

In Summary

Alzheimer's disease is a progressive neurological disorder characterized by memory loss, cognitive decline, and behavioral changes, affecting millions of individuals worldwide. While there is currently no cure for Alzheimer's disease, various treatments and non-pharmacological approaches can help manage symptoms and improve the quality of life for affected individuals. Clinical trials are crucial in advancing Alzheimer's research and developing new therapies, offering new treatments and potential breakthroughs in the field.
By volunteering for clinical trials, individuals can contribute to scientific knowledge, advance Alzheimer's research, and potentially benefit from innovative therapies not yet available to the public.

CenTrial.org is a valuable resource for people interested in participating in clinical trials for Alzheimer's disease and other health conditions, offering a streamlined process for matching participants with relevant research studies. Those affected by Alzheimer's disease, as well as their families and caregivers, may consider registering with CenTrial to receive opportunities to contribute to Alzheimer's research and make a meaningful impact in the fight against this devastating condition.
Alzheimer's and Dementia Resources
Understand Key Factors of Dementia and Clinical Trials

Alzheimer's: Where Do We Go from Here?
NeuroAid Therapy Shows Positive Results in Alzheimer's Disease
Can Brain Stimulation Relieve Pain in Alzheimer's Patients?
Mastinib Shows Promising Results in Alzheimer's Clinical Trial
Semorinenab does not reduce Clinical Decline in Alzheimer's Disease
Alzheimer's Disease Treatment: New Breakthrough for Early Stages
A 17-year Battle Against Alzheimer's

Can Blueberries Reduce Dementia Risk in Insulin-Resistant Individuals?
Detecting Treatment Effects in Lewy Body Dementia: Digital vs. Clinical Assessments
Understand Key Factors of Dementia and Clinical Trials

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.
Find a Trial